The full-day event in September will see a meeting of the Italian Alliance for Personalised Medicine (IAPM), which was launched in Milan earlier this year, followed by an EAPM an-nual general meeting (AGM) to present an overview of activities and goals, as well as to appoint new members to the board.

In consort with EAPM’s ‘Taking Stock’ theme at the 2016 annual conference held in April, the IAPM seeks to take stock of where stakeholders should go next relating to the imple-mentation of the Council conclusions on personalised medicine that were supported by all health ministers during the Luxembourg Presidency of the EU.

The aim remains to support the Member States, the European Commission, the European Parliament, and identify how experts can aid them in shaping an environment for personalised medicine.